2006 Grants

TRANSLATIONAL AWARDS - 2006

Baylor College of Medicine at Texas Children's Hospital, Houston, Texas
Building a Texas-based center for neuroblastoma clinical research
Dr. Heidi Russell

Children's Healthcare of Atlanta (CHOA)
CHOA Experimental Therapy Pediatric Oncology Research
Dr. Howard Katzenstein

Children's Hospital- Denver, Colorado
Expanding Access to New Agents for Cancer Treatment
Dr. Lia Gore

Children's Hospital & Regional Medical Center, Seattle, Washington
Use sophisticated approaches to optimize the effectiveness of current chemotherapy agents, and to develop novel chemotherapy agents
Dr. Julie Park

Children's Hospital of Los Angeles
New Approaches to Neuroblastoma Therapy (NANT) Consortium
Dr. Robert Seeger

Vanderbilt University Medical Center, Nashville, Tennessee
Pediatric Oncology Translational Research Program
Dr. James Whitlock

INNOVATION AWARDS 2006

Baylor College of Medicine at Texas Children's Hospital, Houston, TX
Parallel sequencing to identify the causes of childhood cancer
Dr. Sharon Plon

Dana-Farber Cancer Institute, Boston, Massachusetts
Anti-Angiogenic (Metronomic) Chemotherapy in Children with Poor Prognosis
Dr. Mark Keieran

Dana-Farber Cancer Institute, Boston, Massachusetts
Tyrosine Kinase Mutation Discovery in Neuroblastoma
Dr. Matthew Meyerson

Duke University Medical Center, Durham, North Carolina
Molecular characterization of OTX2 as a novel therapeutic target
Dr. Hai Yan

Duke University Medical Center, Durham, North Carolina
Targeting Pediatric Brainstem Glioma with Oncolytic Polioviruses
Dr. Matthias Gromeier

Johns Hopkins University School of Medicine, Baltimore, Maryland
HMG-I/Y in pediatric Leukemia & Lymphoma
Dr. Linda Smith Resar

YOUNG INVESTIGATOR AWARDS 2006

Children's Healthcare of Atlanta
WIP1 Modulates Responsiveness of MB to Genotoxic Stress
Dr. Robert Castellino

Children's Hospital of Los Angeles
Assess the activity of ABT-737 as a single agent against neuroblastoma cell lines grown in cell culture
Dr. Theresa Harned

Columbus Children's Hospital, Columbus, OH
siRNA knock down of E2A-PBX1 in pediatric ALL
Dr. Mary Elizabeth Ross

Duke University Medical Center, Durham, North Carolina
Pax3-FKHR targets that enable bypass of cellular senescence in rhabdomyosarcoma
Dr. Corinne Mary Linardic

Memorial Sloan Kettering Cancer Center, New York, NY
Hedgehog & IGF signaling through IRSI in Brain devel. & medulloblastoma
Dr. Anna Marie Kenney

Stanford University, Stanford, CA
Modeling osteosarcoma to identify novel therapeutic targets
Dr. Julien Sage

The Children's Hospital of Philadelphia
Anti-Angiogenic Effects of BAI Proteins in Neuroblastoma
Dr. Naomi Balamuth

University of Michigan, Ann Arbor, Michigan
Mechanisms of leukocyte recruitment to the lung during idiopathic pneumonia syndrome following allogeneic bone marrow transplantation
Dr. Sung Won Choi

University of Texas Health Science Center at San Antonio
Children's Cancer Research Institute
Mediators of Metastasis in Alveolar Rhabdomyosarcoma
Dr. Koichi Nishijo

Vanderbilt University Medical Center, Nashville, Tennessee
MTG-16 Regulation by Phosphorylation
Dr. Michael Engel